Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial (CRETE)

What is the purpose of this trial?

The purpose of this phase 2a, multi-center, single arm study, is to explore the efficacy of early prophylaxis against catheter-associated deep venous thrombosis (CADVT) in critically ill children.


Participation Guidelines

Ages: 17 years and younger

Gender: Both


National Institute of Child Health and Human Development

Dates: 04/05/2017 - 06/01/2017

Last Updated: 12/10/2017

Study HIC#: 1302011506

Get Involved

For more information about this study, contact:
Joana Tala
+1 203-785-4651
joana.tala@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Edward Vincent Faustino

Principal Investigator

Sub-Investigators